U.S. authorities have approved a third dose of the Pfizer COVID-19 vaccine for people aged 65 and older and some high-risk groups. The Food and Drug Administration says the booster shot should be administered at least six months after receiving the second dose. The authorization will include people most susceptible to develop severe illness and those in high-risk jobs.